Report Cover

Global Point-of-Care or Rapid Testing Market Research Report 2022


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
    Blood Glucose Testing
    Infectious Diseases Testing
    Cardiac Markers Testing
    Coagulation Testing
    Pregnancy and Fertility Testing
    Blood Gas/Electrolytes Testing
    Urinalysis Testing
    Others
Segment by Application
    Clinics
    Hospitals
    Laboratory
    Others
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
By Company
    Roche
    Abbott
    Johnson & Johnson
    Siemens Healthcare
    Danaher
    Ascensia
    Bio-Rad Laboratories
    BioMerieux
    ARKRAY
    Nova Biomedical
    Trividia Health
    Quidel
    Accriva
    OraSure Technologies
    Helena Laboratories
    A. Menarini Diagnostics
    Abaxis (Zoetis)
    Ortho Clinical Diagnostics
    Phamatech
    Chembio Diagnostics
    Sinocare
    Wondfo
    Yuwell
    Runbio
    KHB
    Wuhan EasyDiagnosis Biomedicine
    DAAN GENE
1 Point-of-Care or Rapid Testing Market Overview
    1.1 Product Overview and Scope of Point-of-Care or Rapid Testing
    1.2 Point-of-Care or Rapid Testing Segment by Type
        1.2.1 Global Point-of-Care or Rapid Testing Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Blood Glucose Testing
        1.2.3 Infectious Diseases Testing
        1.2.4 Cardiac Markers Testing
        1.2.5 Coagulation Testing
        1.2.6 Pregnancy and Fertility Testing
        1.2.7 Blood Gas/Electrolytes Testing
        1.2.8 Urinalysis Testing
        1.2.9 Others
    1.3 Point-of-Care or Rapid Testing Segment by Application
        1.3.1 Global Point-of-Care or Rapid Testing Sales Comparison by Application: (2022-2028)
        1.3.2 Clinics
        1.3.3 Hospitals
        1.3.4 Laboratory
        1.3.5 Others
    1.4 Global Point-of-Care or Rapid Testing Market Size Estimates and Forecasts
        1.4.1 Global Point-of-Care or Rapid Testing Revenue 2017-2028
        1.4.2 Global Point-of-Care or Rapid Testing Sales 2017-2028
        1.4.3 Point-of-Care or Rapid Testing Market Size by Region: 2017 Versus 2021 Versus 2028
2 Point-of-Care or Rapid Testing Market Competition by Manufacturers
    2.1 Global Point-of-Care or Rapid Testing Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Point-of-Care or Rapid Testing Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Point-of-Care or Rapid Testing Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Point-of-Care or Rapid Testing Manufacturing Sites, Area Served, Product Type
    2.5 Point-of-Care or Rapid Testing Market Competitive Situation and Trends
        2.5.1 Point-of-Care or Rapid Testing Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Point-of-Care or Rapid Testing Players Market Share by Revenue
        2.5.3 Global Point-of-Care or Rapid Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Point-of-Care or Rapid Testing Retrospective Market Scenario by Region
    3.1 Global Point-of-Care or Rapid Testing Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Point-of-Care or Rapid Testing Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Point-of-Care or Rapid Testing Market Facts & Figures by Country
        3.3.1 North America Point-of-Care or Rapid Testing Sales by Country
        3.3.2 North America Point-of-Care or Rapid Testing Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Point-of-Care or Rapid Testing Market Facts & Figures by Country
        3.4.1 Europe Point-of-Care or Rapid Testing Sales by Country
        3.4.2 Europe Point-of-Care or Rapid Testing Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Point-of-Care or Rapid Testing Market Facts & Figures by Region
        3.5.1 Asia Pacific Point-of-Care or Rapid Testing Sales by Region
        3.5.2 Asia Pacific Point-of-Care or Rapid Testing Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Point-of-Care or Rapid Testing Market Facts & Figures by Country
        3.6.1 Latin America Point-of-Care or Rapid Testing Sales by Country
        3.6.2 Latin America Point-of-Care or Rapid Testing Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Point-of-Care or Rapid Testing Market Facts & Figures by Country
        3.7.1 Middle East and Africa Point-of-Care or Rapid Testing Sales by Country
        3.7.2 Middle East and Africa Point-of-Care or Rapid Testing Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Point-of-Care or Rapid Testing Historic Market Analysis by Type
    4.1 Global Point-of-Care or Rapid Testing Sales Market Share by Type (2017-2022)
    4.2 Global Point-of-Care or Rapid Testing Revenue Market Share by Type (2017-2022)
    4.3 Global Point-of-Care or Rapid Testing Price by Type (2017-2022)
5 Global Point-of-Care or Rapid Testing Historic Market Analysis by Application
    5.1 Global Point-of-Care or Rapid Testing Sales Market Share by Application (2017-2022)
    5.2 Global Point-of-Care or Rapid Testing Revenue Market Share by Application (2017-2022)
    5.3 Global Point-of-Care or Rapid Testing Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Roche
        6.1.1 Roche Corporation Information
        6.1.2 Roche Description and Business Overview
        6.1.3 Roche Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Roche Point-of-Care or Rapid Testing Product Portfolio
        6.1.5 Roche Recent Developments/Updates
    6.2 Abbott
        6.2.1 Abbott Corporation Information
        6.2.2 Abbott Description and Business Overview
        6.2.3 Abbott Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Abbott Point-of-Care or Rapid Testing Product Portfolio
        6.2.5 Abbott Recent Developments/Updates
    6.3 Johnson & Johnson
        6.3.1 Johnson & Johnson Corporation Information
        6.3.2 Johnson & Johnson Description and Business Overview
        6.3.3 Johnson & Johnson Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Johnson & Johnson Point-of-Care or Rapid Testing Product Portfolio
        6.3.5 Johnson & Johnson Recent Developments/Updates
    6.4 Siemens Healthcare
        6.4.1 Siemens Healthcare Corporation Information
        6.4.2 Siemens Healthcare Description and Business Overview
        6.4.3 Siemens Healthcare Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Siemens Healthcare Point-of-Care or Rapid Testing Product Portfolio
        6.4.5 Siemens Healthcare Recent Developments/Updates
    6.5 Danaher
        6.5.1 Danaher Corporation Information
        6.5.2 Danaher Description and Business Overview
        6.5.3 Danaher Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Danaher Point-of-Care or Rapid Testing Product Portfolio
        6.5.5 Danaher Recent Developments/Updates
    6.6 Ascensia
        6.6.1 Ascensia Corporation Information
        6.6.2 Ascensia Description and Business Overview
        6.6.3 Ascensia Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Ascensia Point-of-Care or Rapid Testing Product Portfolio
        6.6.5 Ascensia Recent Developments/Updates
    6.7 Bio-Rad Laboratories
        6.6.1 Bio-Rad Laboratories Corporation Information
        6.6.2 Bio-Rad Laboratories Description and Business Overview
        6.6.3 Bio-Rad Laboratories Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Bio-Rad Laboratories Point-of-Care or Rapid Testing Product Portfolio
        6.7.5 Bio-Rad Laboratories Recent Developments/Updates
    6.8 BioMerieux
        6.8.1 BioMerieux Corporation Information
        6.8.2 BioMerieux Description and Business Overview
        6.8.3 BioMerieux Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 BioMerieux Point-of-Care or Rapid Testing Product Portfolio
        6.8.5 BioMerieux Recent Developments/Updates
    6.9 ARKRAY
        6.9.1 ARKRAY Corporation Information
        6.9.2 ARKRAY Description and Business Overview
        6.9.3 ARKRAY Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 ARKRAY Point-of-Care or Rapid Testing Product Portfolio
        6.9.5 ARKRAY Recent Developments/Updates
    6.10 Nova Biomedical
        6.10.1 Nova Biomedical Corporation Information
        6.10.2 Nova Biomedical Description and Business Overview
        6.10.3 Nova Biomedical Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Nova Biomedical Point-of-Care or Rapid Testing Product Portfolio
        6.10.5 Nova Biomedical Recent Developments/Updates
    6.11 Trividia Health
        6.11.1 Trividia Health Corporation Information
        6.11.2 Trividia Health Point-of-Care or Rapid Testing Description and Business Overview
        6.11.3 Trividia Health Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Trividia Health Point-of-Care or Rapid Testing Product Portfolio
        6.11.5 Trividia Health Recent Developments/Updates
    6.12 Quidel
        6.12.1 Quidel Corporation Information
        6.12.2 Quidel Point-of-Care or Rapid Testing Description and Business Overview
        6.12.3 Quidel Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Quidel Point-of-Care or Rapid Testing Product Portfolio
        6.12.5 Quidel Recent Developments/Updates
    6.13 Accriva
        6.13.1 Accriva Corporation Information
        6.13.2 Accriva Point-of-Care or Rapid Testing Description and Business Overview
        6.13.3 Accriva Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Accriva Point-of-Care or Rapid Testing Product Portfolio
        6.13.5 Accriva Recent Developments/Updates
    6.14 OraSure Technologies
        6.14.1 OraSure Technologies Corporation Information
        6.14.2 OraSure Technologies Point-of-Care or Rapid Testing Description and Business Overview
        6.14.3 OraSure Technologies Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 OraSure Technologies Point-of-Care or Rapid Testing Product Portfolio
        6.14.5 OraSure Technologies Recent Developments/Updates
    6.15 Helena Laboratories
        6.15.1 Helena Laboratories Corporation Information
        6.15.2 Helena Laboratories Point-of-Care or Rapid Testing Description and Business Overview
        6.15.3 Helena Laboratories Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Helena Laboratories Point-of-Care or Rapid Testing Product Portfolio
        6.15.5 Helena Laboratories Recent Developments/Updates
    6.16 A. Menarini Diagnostics
        6.16.1 A. Menarini Diagnostics Corporation Information
        6.16.2 A. Menarini Diagnostics Point-of-Care or Rapid Testing Description and Business Overview
        6.16.3 A. Menarini Diagnostics Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 A. Menarini Diagnostics Point-of-Care or Rapid Testing Product Portfolio
        6.16.5 A. Menarini Diagnostics Recent Developments/Updates
    6.17 Abaxis (Zoetis)
        6.17.1 Abaxis (Zoetis) Corporation Information
        6.17.2 Abaxis (Zoetis) Point-of-Care or Rapid Testing Description and Business Overview
        6.17.3 Abaxis (Zoetis) Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Abaxis (Zoetis) Point-of-Care or Rapid Testing Product Portfolio
        6.17.5 Abaxis (Zoetis) Recent Developments/Updates
    6.18 Ortho Clinical Diagnostics
        6.18.1 Ortho Clinical Diagnostics Corporation Information
        6.18.2 Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Description and Business Overview
        6.18.3 Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Product Portfolio
        6.18.5 Ortho Clinical Diagnostics Recent Developments/Updates
    6.19 Phamatech
        6.19.1 Phamatech Corporation Information
        6.19.2 Phamatech Point-of-Care or Rapid Testing Description and Business Overview
        6.19.3 Phamatech Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 Phamatech Point-of-Care or Rapid Testing Product Portfolio
        6.19.5 Phamatech Recent Developments/Updates
    6.20 Chembio Diagnostics
        6.20.1 Chembio Diagnostics Corporation Information
        6.20.2 Chembio Diagnostics Point-of-Care or Rapid Testing Description and Business Overview
        6.20.3 Chembio Diagnostics Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.20.4 Chembio Diagnostics Point-of-Care or Rapid Testing Product Portfolio
        6.20.5 Chembio Diagnostics Recent Developments/Updates
    6.21 Sinocare
        6.21.1 Sinocare Corporation Information
        6.21.2 Sinocare Point-of-Care or Rapid Testing Description and Business Overview
        6.21.3 Sinocare Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.21.4 Sinocare Point-of-Care or Rapid Testing Product Portfolio
        6.21.5 Sinocare Recent Developments/Updates
    6.22 Wondfo
        6.22.1 Wondfo Corporation Information
        6.22.2 Wondfo Point-of-Care or Rapid Testing Description and Business Overview
        6.22.3 Wondfo Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.22.4 Wondfo Point-of-Care or Rapid Testing Product Portfolio
        6.22.5 Wondfo Recent Developments/Updates
    6.23 Yuwell
        6.23.1 Yuwell Corporation Information
        6.23.2 Yuwell Point-of-Care or Rapid Testing Description and Business Overview
        6.23.3 Yuwell Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.23.4 Yuwell Point-of-Care or Rapid Testing Product Portfolio
        6.23.5 Yuwell Recent Developments/Updates
    6.24 Runbio
        6.24.1 Runbio Corporation Information
        6.24.2 Runbio Point-of-Care or Rapid Testing Description and Business Overview
        6.24.3 Runbio Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.24.4 Runbio Point-of-Care or Rapid Testing Product Portfolio
        6.24.5 Runbio Recent Developments/Updates
    6.25 KHB
        6.25.1 KHB Corporation Information
        6.25.2 KHB Point-of-Care or Rapid Testing Description and Business Overview
        6.25.3 KHB Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.25.4 KHB Point-of-Care or Rapid Testing Product Portfolio
        6.25.5 KHB Recent Developments/Updates
    6.26 Wuhan EasyDiagnosis Biomedicine
        6.26.1 Wuhan EasyDiagnosis Biomedicine Corporation Information
        6.26.2 Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Description and Business Overview
        6.26.3 Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.26.4 Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Product Portfolio
        6.26.5 Wuhan EasyDiagnosis Biomedicine Recent Developments/Updates
    6.27 DAAN GENE
        6.27.1 DAAN GENE Corporation Information
        6.27.2 DAAN GENE Point-of-Care or Rapid Testing Description and Business Overview
        6.27.3 DAAN GENE Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.27.4 DAAN GENE Point-of-Care or Rapid Testing Product Portfolio
        6.27.5 DAAN GENE Recent Developments/Updates
7 Point-of-Care or Rapid Testing Manufacturing Cost Analysis
    7.1 Point-of-Care or Rapid Testing Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Point-of-Care or Rapid Testing
    7.4 Point-of-Care or Rapid Testing Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Point-of-Care or Rapid Testing Distributors List
    8.3 Point-of-Care or Rapid Testing Customers
9 Point-of-Care or Rapid Testing Market Dynamics
    9.1 Point-of-Care or Rapid Testing Industry Trends
    9.2 Point-of-Care or Rapid Testing Market Drivers
    9.3 Point-of-Care or Rapid Testing Market Challenges
    9.4 Point-of-Care or Rapid Testing Market Restraints
10 Global Market Forecast
    10.1 Point-of-Care or Rapid Testing Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Point-of-Care or Rapid Testing by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Point-of-Care or Rapid Testing by Type (2023-2028)
    10.2 Point-of-Care or Rapid Testing Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Point-of-Care or Rapid Testing by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Point-of-Care or Rapid Testing by Application (2023-2028)
    10.3 Point-of-Care or Rapid Testing Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Point-of-Care or Rapid Testing by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Point-of-Care or Rapid Testing by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Point-of-Care or Rapid Testing Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Point-of-Care or Rapid Testing Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Point-of-Care or Rapid Testing Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Point-of-Care or Rapid Testing Market Competitive Situation by Manufacturers in 2021 Table 5. Global Point-of-Care or Rapid Testing Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Point-of-Care or Rapid Testing Sales Market Share by Manufacturers (2017-2022) Table 7. Global Point-of-Care or Rapid Testing Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Point-of-Care or Rapid Testing Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Point-of-Care or Rapid Testing Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Point-of-Care or Rapid Testing Manufacturing Sites and Area Served Table 11. Manufacturers Point-of-Care or Rapid Testing Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Point-of-Care or Rapid Testing by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care or Rapid Testing as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Point-of-Care or Rapid Testing Sales by Region (2017-2022) & (K Units) Table 16. Global Point-of-Care or Rapid Testing Sales Market Share by Region (2017-2022) Table 17. Global Point-of-Care or Rapid Testing Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Point-of-Care or Rapid Testing Revenue Market Share by Region (2017-2022) Table 19. North America Point-of-Care or Rapid Testing Sales by Country (2017-2022) & (K Units) Table 20. North America Point-of-Care or Rapid Testing Sales Market Share by Country (2017-2022) Table 21. North America Point-of-Care or Rapid Testing Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Point-of-Care or Rapid Testing Revenue Market Share by Country (2017-2022) Table 23. Europe Point-of-Care or Rapid Testing Sales by Country (2017-2022) & (K Units) Table 24. Europe Point-of-Care or Rapid Testing Sales Market Share by Country (2017-2022) Table 25. Europe Point-of-Care or Rapid Testing Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Point-of-Care or Rapid Testing Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Point-of-Care or Rapid Testing Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Point-of-Care or Rapid Testing Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Point-of-Care or Rapid Testing Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Point-of-Care or Rapid Testing Revenue Market Share by Region (2017-2022) Table 31. Latin America Point-of-Care or Rapid Testing Sales by Country (2017-2022) & (K Units) Table 32. Latin America Point-of-Care or Rapid Testing Sales Market Share by Country (2017-2022) Table 33. Latin America Point-of-Care or Rapid Testing Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Point-of-Care or Rapid Testing Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Point-of-Care or Rapid Testing Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Point-of-Care or Rapid Testing Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Point-of-Care or Rapid Testing Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Point-of-Care or Rapid Testing Revenue Market Share by Country (2017-2022) Table 39. Global Point-of-Care or Rapid Testing Sales by Type (2017-2022) & (K Units) Table 40. Global Point-of-Care or Rapid Testing Sales Market Share by Type (2017-2022) Table 41. Global Point-of-Care or Rapid Testing Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Point-of-Care or Rapid Testing Revenue Share by Type (2017-2022) Table 43. Global Point-of-Care or Rapid Testing Price by Type (2017-2022) & (USD/Unit) Table 44. Global Point-of-Care or Rapid Testing Sales (K Units) by Application (2017-2022) Table 45. Global Point-of-Care or Rapid Testing Sales Market Share by Application (2017-2022) Table 46. Global Point-of-Care or Rapid Testing Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Point-of-Care or Rapid Testing Revenue Share by Application (2017-2022) Table 48. Global Point-of-Care or Rapid Testing Price by Application (2017-2022) & (USD/Unit) Table 49. Roche Corporation Information Table 50. Roche Description and Business Overview Table 51. Roche Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. Roche Point-of-Care or Rapid Testing Product Table 53. Roche Recent Developments/Updates Table 54. Abbott Corporation Information Table 55. Abbott Description and Business Overview Table 56. Abbott Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. Abbott Point-of-Care or Rapid Testing Product Table 58. Abbott Recent Developments/Updates Table 59. Johnson & Johnson Corporation Information Table 60. Johnson & Johnson Description and Business Overview Table 61. Johnson & Johnson Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Johnson & Johnson Point-of-Care or Rapid Testing Product Table 63. Johnson & Johnson Recent Developments/Updates Table 64. Siemens Healthcare Corporation Information Table 65. Siemens Healthcare Description and Business Overview Table 66. Siemens Healthcare Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Siemens Healthcare Point-of-Care or Rapid Testing Product Table 68. Siemens Healthcare Recent Developments/Updates Table 69. Danaher Corporation Information Table 70. Danaher Description and Business Overview Table 71. Danaher Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Danaher Point-of-Care or Rapid Testing Product Table 73. Danaher Recent Developments/Updates Table 74. Ascensia Corporation Information Table 75. Ascensia Description and Business Overview Table 76. Ascensia Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Ascensia Point-of-Care or Rapid Testing Product Table 78. Ascensia Recent Developments/Updates Table 79. Bio-Rad Laboratories Corporation Information Table 80. Bio-Rad Laboratories Description and Business Overview Table 81. Bio-Rad Laboratories Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Bio-Rad Laboratories Point-of-Care or Rapid Testing Product Table 83. Bio-Rad Laboratories Recent Developments/Updates Table 84. BioMerieux Corporation Information Table 85. BioMerieux Description and Business Overview Table 86. BioMerieux Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. BioMerieux Point-of-Care or Rapid Testing Product Table 88. BioMerieux Recent Developments/Updates Table 89. ARKRAY Corporation Information Table 90. ARKRAY Description and Business Overview Table 91. ARKRAY Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. ARKRAY Point-of-Care or Rapid Testing Product Table 93. ARKRAY Recent Developments/Updates Table 94. Nova Biomedical Corporation Information Table 95. Nova Biomedical Description and Business Overview Table 96. Nova Biomedical Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Nova Biomedical Point-of-Care or Rapid Testing Product Table 98. Nova Biomedical Recent Developments/Updates Table 99. Trividia Health Corporation Information Table 100. Trividia Health Description and Business Overview Table 101. Trividia Health Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. Trividia Health Point-of-Care or Rapid Testing Product Table 103. Trividia Health Recent Developments/Updates Table 104. Quidel Corporation Information Table 105. Quidel Description and Business Overview Table 106. Quidel Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 107. Quidel Point-of-Care or Rapid Testing Product Table 108. Quidel Recent Developments/Updates Table 109. Accriva Corporation Information Table 110. Accriva Description and Business Overview Table 111. Accriva Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 112. Accriva Point-of-Care or Rapid Testing Product Table 113. Accriva Recent Developments/Updates Table 114. OraSure Technologies Corporation Information Table 115. OraSure Technologies Description and Business Overview Table 116. OraSure Technologies Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 117. OraSure Technologies Point-of-Care or Rapid Testing Product Table 118. OraSure Technologies Recent Developments/Updates Table 119. Helena Laboratories Corporation Information Table 120. Helena Laboratories Description and Business Overview Table 121. Helena Laboratories Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 122. Helena Laboratories Point-of-Care or Rapid Testing Product Table 123. Helena Laboratories Recent Developments/Updates Table 124. A. Menarini Diagnostics Corporation Information Table 125. A. Menarini Diagnostics Description and Business Overview Table 126. A. Menarini Diagnostics Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 127. A. Menarini Diagnostics Point-of-Care or Rapid Testing Product Table 128. A. Menarini Diagnostics Recent Developments/Updates Table 129. Abaxis (Zoetis) Corporation Information Table 130. Abaxis (Zoetis) Description and Business Overview Table 131. Abaxis (Zoetis) Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 132. Abaxis (Zoetis) Point-of-Care or Rapid Testing Product Table 133. Abaxis (Zoetis) Recent Developments/Updates Table 134. Ortho Clinical Diagnostics Corporation Information Table 135. Ortho Clinical Diagnostics Description and Business Overview Table 136. Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 137. Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Product Table 138. Ortho Clinical Diagnostics Recent Developments/Updates Table 139. Phamatech Corporation Information Table 140. Phamatech Description and Business Overview Table 141. Phamatech Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 142. Phamatech Point-of-Care or Rapid Testing Product Table 143. Phamatech Recent Developments/Updates Table 144. Chembio Diagnostics Corporation Information Table 145. Chembio Diagnostics Description and Business Overview Table 146. Chembio Diagnostics Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 147. Chembio Diagnostics Point-of-Care or Rapid Testing Product Table 148. Chembio Diagnostics Recent Developments/Updates Table 149. Sinocare Corporation Information Table 150. Sinocare Description and Business Overview Table 151. Sinocare Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 152. Sinocare Point-of-Care or Rapid Testing Product Table 153. Sinocare Recent Developments/Updates Table 154. Wondfo Corporation Information Table 155. Wondfo Description and Business Overview Table 156. Wondfo Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 157. Wondfo Point-of-Care or Rapid Testing Product Table 158. Wondfo Recent Developments/Updates Table 159. Yuwell Corporation Information Table 160. Yuwell Description and Business Overview Table 161. Yuwell Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 162. Yuwell Point-of-Care or Rapid Testing Product Table 163. Yuwell Recent Developments/Updates Table 164. Runbio Corporation Information Table 165. Runbio Description and Business Overview Table 166. Runbio Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 167. Runbio Point-of-Care or Rapid Testing Product Table 168. Runbio Recent Developments/Updates Table 169. KHB Corporation Information Table 170. KHB Description and Business Overview Table 171. KHB Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 172. KHB Point-of-Care or Rapid Testing Product Table 173. KHB Recent Developments/Updates Table 174. Wuhan EasyDiagnosis Biomedicine Corporation Information Table 175. Wuhan EasyDiagnosis Biomedicine Description and Business Overview Table 176. Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 177. Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Product Table 178. Wuhan EasyDiagnosis Biomedicine Recent Developments/Updates Table 179. DAAN GENE Corporation Information Table 180. DAAN GENE Description and Business Overview Table 181. DAAN GENE Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 182. DAAN GENE Point-of-Care or Rapid Testing Product Table 183. DAAN GENE Recent Developments/Updates Table 184. Production Base and Market Concentration Rate of Raw Material Table 185. Key Suppliers of Raw Materials Table 186. Point-of-Care or Rapid Testing Distributors List Table 187. Point-of-Care or Rapid Testing Customers List Table 188. Point-of-Care or Rapid Testing Market Trends Table 189. Point-of-Care or Rapid Testing Market Drivers Table 190. Point-of-Care or Rapid Testing Market Challenges Table 191. Point-of-Care or Rapid Testing Market Restraints Table 192. Global Point-of-Care or Rapid Testing Sales Forecast by Type (2023-2028) & (K Units) Table 193. Global Point-of-Care or Rapid Testing Sales Market Share Forecast by Type (2023-2028) Table 194. Global Point-of-Care or Rapid Testing Revenue Forecast by Type (2023-2028) & (US$ Million) Table 195. Global Point-of-Care or Rapid Testing Revenue Market Share Forecast by Type (2023-2028) Table 196. Global Point-of-Care or Rapid Testing Sales Forecast by Application (2023-2028) & (K Units) Table 197. Global Point-of-Care or Rapid Testing Sales Market Share Forecast by Application (2023-2028) Table 198. Global Point-of-Care or Rapid Testing Revenue Forecast by Application (2023-2028) & (US$ Million) Table 199. Global Point-of-Care or Rapid Testing Revenue Market Share Forecast by Application (2023-2028) Table 200. Global Point-of-Care or Rapid Testing Sales Forecast by Region (2023-2028) & (K Units) Table 201. Global Point-of-Care or Rapid Testing Sales Market Share Forecast by Region (2023-2028) Table 202. Global Point-of-Care or Rapid Testing Revenue Forecast by Region (2023-2028) & (US$ Million) Table 203. Global Point-of-Care or Rapid Testing Revenue Market Share Forecast by Region (2023-2028) Table 204. Research Programs/Design for This Report Table 205. Key Data Information from Secondary Sources Table 206. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Point-of-Care or Rapid Testing Figure 2. Global Point-of-Care or Rapid Testing Market Share by Type in 2021 & 2028 Figure 3. Blood Glucose Testing Product Picture Figure 4. Infectious Diseases Testing Product Picture Figure 5. Cardiac Markers Testing Product Picture Figure 6. Coagulation Testing Product Picture Figure 7. Pregnancy and Fertility Testing Product Picture Figure 8. Blood Gas/Electrolytes Testing Product Picture Figure 9. Urinalysis Testing Product Picture Figure 10. Others Product Picture Figure 11. Global Point-of-Care or Rapid Testing Market Share by Application in 2021 & 2028 Figure 12. Clinics Figure 13. Hospitals Figure 14. Laboratory Figure 15. Others Figure 16. Global Point-of-Care or Rapid Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 17. Global Point-of-Care or Rapid Testing Market Size (2017-2028) & (US$ Million) Figure 18. Global Point-of-Care or Rapid Testing Sales (2017-2028) & (K Units) Figure 19. Point-of-Care or Rapid Testing Sales Share by Manufacturers in 2021 Figure 20. Global Point-of-Care or Rapid Testing Revenue Share by Manufacturers in 2021 Figure 21. The Global 5 and 10 Largest Point-of-Care or Rapid Testing Players: Market Share by Revenue in 2021 Figure 22. Point-of-Care or Rapid Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 23. Global Point-of-Care or Rapid Testing Sales Market Share by Region (2017-2022) Figure 24. Global Point-of-Care or Rapid Testing Sales Market Share by Region in 2021 Figure 25. Global Point-of-Care or Rapid Testing Revenue Market Share by Region (2017-2022) Figure 26. Global Point-of-Care or Rapid Testing Revenue Market Share by Region in 2021 Figure 27. U.S. Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Canada Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Germany Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. France Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. U.K. Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Italy Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Russia Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. China Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Japan Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. South Korea Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. India Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Australia Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Taiwan Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Indonesia Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Thailand Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Malaysia Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Philippines Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Vietnam Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Mexico Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. Brazil Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 47. Argentina Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 48. Turkey Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 49. Saudi Arabia Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 50. U.A.E Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million) Figure 51. Sales Market Share of Point-of-Care or Rapid Testing by Type (2017-2022) Figure 52. Manufacturing Cost Structure of Point-of-Care or Rapid Testing Figure 53. Manufacturing Process Analysis of Point-of-Care or Rapid Testing Figure 54. Point-of-Care or Rapid Testing Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us